Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy

This publication has 19 references indexed in Scilit:

• CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results
  Urology, 1999
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update
  Published by American Medical Association (AMA) ,1997
• Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: Experimental and clinical results
  Urology, 1997
• Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy
  Cancer, 1997
• A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma
  Cancer, 1997
• Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer
  Journal of Urology, 1995
• Prostate-specific antigen and radiation therapy for clinically localized prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1995
• Can Radical Prostatectomy Alter the Progression of Poorly Differentiated Prostate Cancer?
  Journal of Urology, 1994